Asia Playing A More Important Role In Global Clinical Trials: World Pharma Trials Asia
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - With big pharmaceutical firms increasing their focus on emerging markets, more and more trials are now being conducted across Asia, including China, India, Turkey and South Korea, speakers at World Pharma Trials Asia 2010 said Sept. 14 in Shanghai
You may also be interested in...
Takeda Takes Global Expansion Next Door To South Korea
TOKYO - Takeda, Japan's largest drug manufacturer by sales, made an announcement June 23 that may come as a surprise. This year, the company hopes to establish its own commercial presence in South Korea, one of Japan's closest neighbors and one of Asia's largest markets
More Talks Needed With China and Japan For Cooperation In Sharing Clinical Data - Korea FDA Official
SEOUL - Although drug regulatory officials from South Korea, Japan and China met in Beijing for two days from Dec. 17 in their second tri-party meeting, they failed to report "noticeable progress" in their pursuit of an integrated clinical trial data-sharing program and mutual acceptance of their rules and guidelines, according to Korea FDA
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).